The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Arthralgia During Anastrozole Therapy for Breast Cancer
Official Title: A Multicentre, Open Study Assessing Joint Disorders Under ARIMIDEX® (1mg/Day) as Adjuvant Treatment in Post Menopausal Women With Early Breast Cancer
Study ID: NCT00323479
Brief Summary: The purpose of this study is to describe the joint symptoms and structural joint changes under anastrozole as adjuvant treatment in postmenopausal women with early breast cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Research Site, Bordeaux, , France
Research Site, Caen, , France
Research Site, Lyon, , France
Research Site, Paris, , France
Research Site, Poitiers, , France
Name: AstraZeneca France Medical Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR